Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population

Oral Health and COVID 19 Clinical Trial

Official title:

Oral Manifestation of COVID19

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04391881
• Other study ID #: 54678
• Status: Recruiting
• Start date: May 30, 2020
• Est. completion date: August 30, 2020

Study information

• Verified date: July 2020
• Source: Cairo University
• Contact: Dina Mounir Elkady, Phd
• Phone: 01004297317
• Email: Dina.elkady[@]dentistry.cu.edu.eg
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The oral manifestation of COVID 19 that could help in the diagnosis of patient

Description:

Oral ulceration,oral lesion,sensitivity that has been reported by patient tested positive for COVID 19

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 500
• Est. completion date: August 30, 2020
• Est. primary completion date: August 30, 2020
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• Tested COVID positive

• No other chronic disease that has oral manifestation

• Above 18

Exclusion Criteria:

• Children

• Patient with no COVID positive

Related Conditions & MeSH terms

• Oral Health and COVID 19
• Oral Manifestations

Locations

Country	Name	City	State
Egypt	Cairo university	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Oral manifestation	The presence or absence or oral manifestation like ulcer burning sensation..will be measured by yes or no using a list of question	1month